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Accumulated evidence suggests that an abnormal placentation and an altered
expression of a variety of trophoblast transporters are associated to preeclampsia. In this
regard, an abnormal expression of AQP3 and AQP9 was reported in these placentas.
Recent data suggests that placental AQPs are not only water channel proteins and that
may participate in relevant processes required for a normal placental development, such
as cell migration and apoptosis. Recently we reported that a normal expression of AQP3
is required for the migration of extravillous trophoblast (EVT) cells. Thus, alterations in
this protein might lead to an insufficient transformation of the maternal spiral arteries
resulting in fluctuations of oxygen tension, a potent stimulus for oxidative damage and
trophoblast apoptosis. In this context, the increase of oxygen and nitrogen reactive
species could nitrate AQP9, producing the accumulation of a non-functional protein
affecting the survival of the villous trophoblast (VT). This may trigger the exacerbated
release of apoptotic VT fragments into maternal circulation producing the systemic
endothelial dysfunction underlying the maternal syndrome. Therefore, our hypothesis is
that the alteration in the expression of placental AQPs observed at the end of gestation
may take place during the trophoblast stem cell differentiation, disturbing both EVT and
VT cells development, or during the VT differentiation and turnover. In both situations,
VT is affected and at last the maternal vascular system is activated leading to the clinical
manifestations of preeclampsia.
Keywords: extravillous trophoblast, villous trophoblast, AQP3, AQP9, human placenta, preeclampsia
INTRODUCTION
Preeclampsia is a pregnancy complication characterized by high blood pressure and proteinuria
which usually begins abruptly after 20 weeks of gestation. This condition is exclusively for human
gestation and affects 7–10% of pregnancies worldwide (Giachini et al., 2017). In Latin-American
countries, it is estimated that 26% of maternal deaths are related to preeclampsia (Khan et al., 2006;
Abalos et al., 2013).
The consequences of preeclampsia are not limited to the pregnancy and may conduce to
maternal permanent vascular and metabolic damage and future heart diseases. Moreover, emerging
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evidence suggests that the adaptation to an adverse intrauterine
environment may also affect the adult life of the newborn
(Giachini et al., 2017).
Despite the importance of preeclampsia and several decades
of extensive research, its etiopathogenesis remains unclear. It
is well accepted that defects in placentation are the main
predisposing factors for preeclampsia (Myatt, 2002; Huppertz,
2008; Hawfield and Freedman, 2009). However, the molecular
basis of the abnormal placental development has not been
sufficiently clarified yet. Several theories have been proposed
to elucidate the origins of preeclampsia but none of them can
explain the variability of cases. In fact, preeclampsia is a very
heterogeneous syndrome and is classified by the severity of the
disease as mild, moderate, and severe and by the time of delivery
as early and late onset preeclampsia, with or without fetal growth
restriction (Huppertz, 2008).
The most cited hypothesis on the etiology of preeclampsia
considers this syndrome as a two-stage disorder (Hawfield and
Freedman, 2009). The first stage is characterized by an insufficient
transformation of the maternal spiral arteries resulting in a
decrease in blood supply to the fetoplacental unit. Consequently,
fluctuation in oxygen levels may increase the damage of the
villous trophoblast (VT) concluding in the maternal endothelial
dysfunction and the clinical manifestations of preeclampsia.
Nevertheless, the link between preeclampsia and a failure of
trophoblast invasion has recently raised serious doubts because
the abnormal transformation of the uterine spiral arteries gives
rise to the maternal symptoms only in some women (Huppertz,
2008, 2018). That is why, the current view regarding the
etiology of preeclampsia has been recently updated toward the
dysregulation of VT turnover.
In this regard, it was proposed that failures in the
differentiation of the villous syncytiotrophoblast could accelerate
the shedding of apoptotic syncytial aggregates (Norah et al.,
2013). The detachment from the apical syncytiotrophoblast
membrane of these structures into the maternal circulation,
induce an antiangiogenic environment and enhance the maternal
systemic inflammatory response producing the endothelial
dysfunction. (Huppertz, 2008, 2018; Norah et al., 2013). Even
more, a failure in the undifferentiated trophoblast stem cells,
may affect VT and EVT lineage resulting also in an inadequate
transformation of the uterine spiral arteries. In this condition,
preeclampsia is associated with growth restriction (Huppertz,
2008, 2018).
Villous syncytiotrophoblast is involved in the fetal-maternal
oxygen and nutrient exchange, and many placental transporters
and channels are altered in preeclamptic placentas (Damiano
et al., 2006; del Monaco et al., 2006; Castro-Parodi et al.,
2009; Dietrich et al., 2013; Martínez et al., 2016; Szpilbarg and
Damiano, 2017).
WATER TRANSPORT AND PLACENTAL
AQUAPORINS
Fetal water requirements increase throughout gestation
accompanying fetal growth. Emerging evidence show that
water can pass across the placenta by transcellular and
paracellular pathways, but the molecular mechanisms of
these processes are not clarified yet. Previous research using
isolated membrane vesicles showed that water moves through
the syncytiotrophoblasts by lipid diffusion (Edwards et al., 1993;
Jansson and Illsley, 1993; Jansson et al., 1999) discarding the
transcellular route and the participation of water-channel cell
membrane proteins known as aquaporins (AQPs).
However, in 2001 we described that AQP3 and AQP9
are present in the apical membrane of the human
syncytiotrophoblast (Damiano et al., 2001). Both proteins
are members of the aquaglyceroporin subfamily and allow the
transport of water, urea, and glycerol. Exceptionally, AQP9 also
facilitates the flux of neutral solutes such as monocarboxylates,
purines, and pyrimidines (Ishibashi et al., 1998; Tsukaguchi et al.,
1998). Uptake experiments showed that these AQPs may mediate
the transcellular water, urea, and glycerol transport in human
placenta (Damiano et al., 2006; Table 1).
However, in preeclamptic placentas we found that the
expression of AQP9 increased and the cellular distribution of this
protein changed, being localized not only in the apical and basal
membranes but also in the cytosol of the syncytiotrophoblasts
(Damiano et al., 2006). In contrast, we have recently reported
that AQP3 expression considerably decreased in preeclamptic
placentas compared to normal ones (Szpilbarg and Damiano,
2017).
Regarding AQPs functionality, water, and mannitol uptakes
also decreased in preeclamptic placentas, compared to normal
TABLE 1 | Expression and functionality of AQP3 and AQP9 in normotensive and
preeclamptic placentas.
Normotensive Placentas Preeclamptic Placentas
AQP3 EXPRESSION Yes (Damiano et al., 2001;













AQP9 expression Yes (Damiano et al., 2001) Yes, increased (Damiano
et al., 2006)
AQP9 localization Apical membrane of
syncytiotrophoblast cells






(Damiano et al., 2006)
WATER UPTAKE,
pmol. g−1.min−1
Control 76 ± 6 47 ± 10∗
+ HgCl2 0.3mM 48 ± 7# 36 ± 12
(Damiano et al., 2006) (Damiano et al., 2006)
Mannitol Uptake,
pmol. g−1.min−1
Control 14.6 ± 0.3 5.5 ± 0.6∗
+ HgCl2 0.3mM 7.8 ± 0.8# 6.0 ± 2.3
(Damiano et al., 2006) (Damiano et al., 2006)
∗P < 0.05 normotensive vs. preeclamptic placentas. #P < 0.05 in the absence vs.
in the presence of HgCl2, a general blocker of AQPs.
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ones and were not sensitive to HgCl2 (Damiano et al., 2006;
Table 1).
Although the reduced uptake of water may be associated to
AQP3 expression, the lack of sensitivity to HgCl2 and the reduced
uptake of mannitol, which can only permeate through AQP9,
may suggest that both proteins are not functional in preeclamptic
placentas.
Given that there is no evidence that the water fetal-maternal
flux is altered in preeclampsia, the classical role of these placental
AQPs exclusively in facilitation of trans-epithelial fluid transport
has been called into question (Damiano, 2011; Martínez and
Damiano, 2017). Recently, unexpected cellular roles of AQPs
were reported, including organelle physiology, proliferation,
apoptosis, and cell migration (Verkman, 2011; Kitchen et al.,
2015). All of them are related to temporary cell volume
changes.
It is important to note that human placenta is
hemomonochorial, in which the syncytiotrophoblast, a single
layer of polarized epithelium separates the maternal and fetal
circulation (Stulc, 1997). Because of the similarities in the
fetal-maternal transfer barrier, the guinea pig is the only animal
model established to study placental transport. Despite of this,
several studies were carried out in mice, rats, and sheep reporting
changes in the expression of AQPs during pregnancy that could
be associated with changes in placental water transfer and
amniotic fluid homeostasis (Liu et al., 2004; Beall et al., 2007;
Belkacemi et al., 2011). In addition, AQP3-knockout mice were
viable and developed normally, but no studies ruled out placental
or pregnancies alterations in these mice (Verkman, 2006; Lei
et al., 2017).
On the other hand, preeclampsia is a disorder unique to
human pregnancy, and no animal model could reproduce the
complete syndrome. Taken into account these difficulties, the role
of AQPs in human preeclamptic placenta was studied by in vitro
models (Martínez and Damiano, 2017).
OXYGEN REGULATION OF PLACENTAL
AQUAPORINS
It is well known that trophoblast differentiation is regulated
by oxygen (Genbacev et al., 1997; James et al., 2006).
During normal pregnancies, placentation occurs in a relatively
hypoxic environment. Hypoxia inducible factor-1α (HIF-1α)
may contribute to the adaptation of the placenta to fluctuations
in the oxygen tensions (Patel et al., 2010).
In pathological conditions, intermittent hypoxia because of
the decreased maternal blood flow into the intervillous space may
produce an ischemia/reperfusion insult in the placenta (Hung
and Burton, 2006).
Since hypoxia controls the expression of many genes involved
in cell adaptation to stress, the regulation of placental AQPs
by oxygen was studied. In normal placental explants exposed
to oxygen deprivation, HIF-1α was detected and AQP9 protein
drastically decreased (Castro-Parodi et al., 2013). However,
in explants cultured in hypoxia/reoxygenation, HIF-1α was
undetectable and AQP9 showed a significant increased. In
this condition, we also observed that AQP9 was localized
in the apical and basal membranes and in the cytosol of
the syncytiotrophoblast as previously reported in preeclamptic
placentas (Damiano et al., 2006; Castro-Parodi et al., 2013).
Regarding AQP3, hypoxia decreased the protein expression
which was abnormally localized in the cytosol. After
reoxygenation, AQP3 returned to the apical membrane of
the syncytiotrophoblast, but its expression was not restored to
control levels (Szpilbarg et al., 2016).
PLACENTAL AQUAPORINS AND
APOPTOSIS
Trophoblast apoptosis increases progressively during gestation.
This physiological process is required for normal turnover of VT
and comprises the fusion of the mononuclear cytotrophoblast
cells into the multinucleate syncytium (Smith and Baker,
1999; Huppertz et al., 2006; Sharp et al., 2010). These events
lead to the release into maternal circulation of syncytial
aggregates, which progressively increase during normal
pregnancy and do not harm the mother (Burton and Jones,
2009).
In pregnancies complicated by preeclampsia, VT apoptosis
is exacerbated compared to normotensive pregnancies (Sharp
et al., 2010). It was proposed that an altered balance between
proliferation and apoptosis could increase the formation of
syncytial aggregates shedding into the maternal circulation.
This favors the immunological and inflammatory processes
of the mother and promotes the systemic endothelial
dysfunction (Huppertz, 2008; Norah et al., 2013; Roland
et al., 2016).
Concerning the role of AQPs in the programmed cell death,
Jablonski et al. (2004) demonstrated that AQPs may mediate
the loss water and subsequent cell shrinkage in the apoptotic
cells. The proposed mechanism is that the K+ efflux and the
intracellular K+ depletion generate an osmotic gradient that
drives water out of the cell, a process known as apoptotic
volume decrease (AVD). Inactivation of AQPs after AVD and
the continuous efflux of ions K+ decrease the ionic strength of
the cytoplasm and activate the apoptotic caspases. (Chen et al.,
2008).
Given this background, we studied the role of AQPs in the
VT apoptosis. We observed that only the inhibition of AQP3
abrogates the apoptotic response of these cells (Szpilbarg et al.,
2016). Thus, we provided evidence that AQP3 may be important
in the regulation of VT apoptosis and consequently an abnormal
expression of this protein could alter this tightly regulated
process.
Along with this idea, we expected that an altered AQP3 may be
one of the key factors in the development of preeclampsia. In this
context, we assumed that the increase in trophoblast apoptosis
observed in preeclampsia might correlate with an increase in
AQP3, but we found a reduced expression of this protein in these
placentas (Szpilbarg and Damiano, 2017). Consequently, the role
of AQP3 in the apoptosis of the VT in preeclampsia remains
unclear.
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One possibility is that AQP3 decreases as an adaptive response
of the trophoblast to reduce the apoptotic events observed in
preeclampsia.
Another possible explanation is that the damage to the
syncytiotrophoblast membranes produced by the intermittent
hypoxia may create an unfavorable environment for AQP3
insertion into the plasma membrane, increasing its degradation.
In fact, the apical membranes of syncytiotrophoblast from
preeclamptic placentas are more rigid than normal ones, due to
an increase in sphingomyelin that reduces the number of caveolae
and the expression of Caveolin-1 (Levi et al., 2016). Moreover,
analysis of the primary structure of AQPs revealed a putative
caveolin-1-binding site which is required for AQPs functionality
(Jablonski and Hughes, 2006). Consequently, an altered lipid
composition may disrupt the ability of sphingomyelin and
cholesterol to assemble into caveolae in the apical leaflet of the
bilayer, affecting protein expression and cell signaling (Levi et al.,
2016).
Regarding AQP9, we found that its blocking did not
prevent the apoptotic response of the trophoblast (Szpilbarg
et al., 2016), discarding a direct role of the AQP9 in this
process. Furthermore, despite the increase in AQP9 protein
expression, we observed a lack of its functionality for water and
monocarboxylates in preeclamptic placentas (Damiano et al.,
2006).
The placenta is a main source of reactive oxygen (ROS)
and nitrogen (RNS) species which can nitrate tyrosine sites of
proteins by enhancing the production of peroxynitrite (Webster
et al., 2008; Myatt, 2010). Nitration of proteins can cause a
loss of function. In recent studies (unpublished), we observed
an increase of 3-nitrotyrosine AQP9 in preeclamptic placentas.
In this context, we propose that this nitrated protein may
impair the transfer of lactate, an end-product of anaerobic
glycolysis.
Evidence suggests that AQP9 could play a role both in energy
metabolism and in the clearance of free radicals. Recently, it was
reported in preeclamptic placentas, a significant decrease in the
protein expression and the function of GLUT-1 (Lüscher et al.,
2017). Therefore, faced with the reduction of the glucose passage,
the trophoblast might be forced to use another source of energy
like lactate (Lüscher et al., 2017).
Lactate is an energy substrate and can also be involved in
scavenging ROS as a source of NADH (Schurr and Gozal, 2011).
Although the expression of monocarboxylate symporters MCT1
and MCT4 has been found in syncytiotrophoblast membranes
(Settle et al., 2004), no data was found about their expression in
preeclamptic placentas. For that reason, we hypothesize that the
lack of functionality of AQP9 may increase ROS accumulation
and adversely affect the survival of the trophoblast cells, like in
other tissues (Miki et al., 2013; Akashi et al., 2015). Therefore,
AQP9 may contribute to exacerbate the trophoblast apoptosis in
an indirect manner.
In addition, supraphysiological concentrations of
peroxynitrite can induce a decrease of protein degradation
rates by the proteasome (Grune et al., 1998). Subsequently,
we surmise that the changes in the cellular distribution
of AQP9, observed in preeclamptic placentas (Damiano
et al., 2006), may be due to the increase of this non-
functional nitrated protein that cannot be degraded in
the proteasome and accumulates in the cytosol of the
syncytiotrophoblasts.
Given that preeclampsia is a syndrome of early placentation,
we cannot discard that the abnormal expression of AQP3 and
AQP9 observed at the end of gestation may be a consequence of
a failure in the differentiation of the trophoblast stem cell. In this




To date, many AQPs were described in the blastocyst and in the
early and term placenta (Escobar et al., 2012; Xiong et al., 2013).
AQP3, AQP1, and AQP9 are the most abundant AQPs expressed
in chorionic villi from first trimester suggesting that they may
have a key role in the normal fetal growth and homeostasis.
A highly synchronized trophoblast differentiation,
proliferation, and invasion are necessary to achieve a successful
pregnancy. Nowadays, the molecular mechanisms that lead
these complex processes remain unknown. Trophoblast cells
differentiate to invasive extravillous trophoblast (EVT) or
fuse to form the syncytium (Velicky et al., 2016). Thereby,
EVT cells change their epithelial phenotype to an invasive
mesenchymal phenotype. These events resemble the general
epithelial-mesenchymal transition process and allow EVT to
invade the endometrium. (DaSilva-Arnolda et al., 2015; Davies
et al., 2016). In these processes, mechanisms of migration
and invasion displayed by trophoblast and malignant cells are
similar. However, unlike tumors, the trophoblast behavior is
tightly controlled (Soundararajan and Jagannadha Rao, 2004;
Piechowski, 2016).
Moreover, increasing evidence demonstrated that AQPs may
be involved in tumor cell migration. (Hu and Verkman, 2006;
Nico and Ribatti, 2011; Cao et al., 2013; Ribatti et al., 2014; Marlar
et al., 2017).
Considering that preeclampsia is related to an abnormal
placentation and an altered placental expression of AQP3 and
AQP9 was found after the onset of the maternal syndrome, we
assumed that these proteins may participate in the early stages of
placental development.
Along with this idea, we explored the contribution of AQPs to
the EVT cell migration.
Our findings strongly show that only the blocking of AQP3
or the silencing of its expression reduce trophoblast cells
migration. AQP9 is not involved in this process (Reca et al.,
2018).
We believe that in preeclampsia complicated by IUGR,
the aberrant expression of AQP3 may be present already
in the undifferentiated trophoblast stem cell affecting both
VT and EVT pathways. However, up to now, it is not
possible to determine the expression or functionality of
AQPs in early placentas that late in gestation will develop
preeclampsia.
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PUTATIVE PARTICIPATION OF AQP3
AND AQP9 IN THE PHYSIOPATHOLOGY
OF PREECLAMPSIA
Emerging data suggests that placental AQPs may participate in
relevant processes required for a normal placental development,
such as cell migration and apoptosis (Szpilbarg et al., 2016; Reca
et al., 2018).
The alteration in the expression of placental AQPs observed
at the end of gestation may take place at two different steps
during the trophoblast differentiation: (i) during the trophoblast
stem cell differentiation disturbing both EVT and VT cells
development or (ii) during the VT differentiation and turnover.
In both situations, the expression of AQPs in VT is affected
and ultimately this may contribute with the development of the
clinical symptoms of preeclampsia.
Figure 1 is a theoretical representation of our hypothesis of
the putative contribution of AQPs to the multiple alterations
that lead to the development of preeclampsia. In the first case
(i), if the aberrant expression of AQP3 occurs during the first
differentiation step of the trophoblast cell lineage or slightly
afterward, it may affect EVT as well as VT development. Since
AQP3 is required for the appropriated migration of EVT cells
(Reca et al., 2018), the abnormal expression of this protein,
might lead to a shallow trophoblast invasion and insufficient
transformation of the maternal spiral arteries. In this situation,
intermittent hypoxia affects placentation increasing ROS and
RNS, a potent stimulus for VT apoptosis (Myatt and Cui, 2004;
Hung and Burton, 2006). Our hypothesis is that the increase of
ROS and RNS may lead to the nitration of AQP9, resulting in a
non-functional protein. In this scenario, the lack of functionality
of AQP9, may impair the transfer of lactate and promote
more accumulation of ROS and enhance the VT cell death.
This may trigger the exacerbated release of apoptotic syncytial
aggregates into maternal circulation producing the systemic
endothelial dysfunction underlying the maternal syndrome. The
consequences of this set of alterations may lead to preeclampsia
associated to growth restriction.
On the other hand (case ii), we propose that if the abnormal
expression of AQP3 takes place only in the villous pathway, it
may contribute, together with AQP9, to exacerbate the oxidative
damage and apoptotic response of the trophoblast, increasing
FIGURE 1 | Hypothesis of the participation of AQP3 and AQP9 in the physiopathology of preeclampsia: (i) Alterations in AQPs expression may occur during the
trophoblast stem cell differentiation disturbing both extravillous and villous trophoblast cells development resulting in preeclampsia with fetal growth restriction. (ii)
Alterations in AQPs expression occur during villous trophoblast differentiation resulting in preeclampsia without fetal growth restriction. In both scenarios, villous
trophoblast cells are affected.
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the shedding of trophoblast material into maternal circulation.
Finally, this may collaborate to induce the injury of
endothelial cells, resulting in preeclampsia without growth
restriction.
In conclusion, abnormal expression of placental AQPs
may appear at different points of trophoblast differentiation
affecting VT alone or VT and EVT cells. Although
preeclampsia is a complex and multisystemic disorder
resulting from multiple simultaneous mechanisms, AQPs
may be contributing as part of this network of alterations
that give rise to the diverse clinical manifestations of
preeclampsia.
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